Wegovy is no longer just a weight-loss drug

Novo Nordisk, the Danish drug maker whose fortunes have soared on the popularity of its GLP-1 agonist drugs, scored a long-sought label expansion for its weight-loss drug Wegovy on Friday, with FDA approving it to reduce the risk of major cardiovascular events in adults who are obese or overweight…#novonordisk #danish #glp1 #fda #obese #elililly #novo #denmark #novoholdings #catalent
Source: Reuters: Health - Category: Consumer Health News Source Type: news